Article Text


AB0223 Evaluation of classical nsaids and cox-2 selective inhibitors on purified ovine enzymes and human whole blood
  1. X De Leval1,
  2. JM Dogne1,
  3. J Delarge1,
  4. JY Reginster2,
  5. Y enrotin2
  1. 1Department of Medicinal Chemistry
  2. 2Bone and Cartilage Metabolism Research Unit, Institute of Pathology, CHU Start-Tilman, Liège, Belgium


Objectives In this study, we evaluated the cyclooxygenases (COX) inhibitory profile of NSAIDs in a cellular assay using human whole blood.

Methods Human whole blood assay was performed using fresh blood from normal volunteers. COX-1 assay: Fresh blood was collected into tubes containing no anticoagulants, vortexed and incubated at 37°C under constant agitation for 1 h to allow the blood clot. The serum was then obtained by centrifugation and was assayed for thromboxane B2 (TXB2) using a enzyme immunoassay. COX-2 assay: Fresh blood was collected in heparinized tubes and activated by treatment with lipopolysaccharide at the final concentration of 100 μg/ml. After 24 h of incubation with the drugs, plasma was collected and assayed for prostaglandin E2 (PGE2). PGE2 production was quantified by a specific radioimmunoassay. Drugs were tested at the concentrations ranged among 0.01 to 100 μmol/l.

Abstract AB0223 Table 1

Conclusion In the whole blood test and based on the IC50 values, the majority of the NSAID tested preferentially inhibits COX-2. Aceclofenac shows the best selectivity whereas indomethacin preferentially inhibited COX-1.

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.